PT

Proviva Therapeutics

Boston, United States · Founded 2019 · $48.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$48.0M
Last Round
$30.0M Extension RoundDec 2025
Rounds
2

About

Proviva Therapeutics is a clinical-stage biotechnology company founded in 2019 and headquartered in Boston, Massachusetts, pioneering novel immuno-cytokine therapeutics for cancer treatment. The company's proprietary pro-cytokine fusion protein platform engineers conditionally active cytokines that remain dormant in healthy tissue and activate selectively in the tumor microenvironment, improving therapeutic window. Its lead program PTX-912 is a first-in-class PD-1 antibody–IL-2 pro-drug fusion protein currently in Phase 1 clinical trials for locally advanced and metastatic solid tumors. Proviva is backed by OrbiMed and Viva BioInnovator.

Summary

Proviva Therapeutics is a Biotech company based in Boston, United States, founded in 2019. It has raised $48.0M in total across 2 rounds, most recently a $30.0M Extension Round round in Dec 2025. Investors include OrbiMed, Longpan Investment and Hankang Capital.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Extension RoundExtension RoundDec 2025
$30.0M

Sign up to see all 2 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Proviva Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/proviva-therapeutics"><img src="https://indexed.vc/api/badge/company/proviva-therapeutics" alt="Proviva Therapeutics on Indexed.vc" width="260" height="76" /></a>